Daria A Naumova

Ms. Daria A Naumova


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
DNDaria A Naumova
Daria A Naumova
TKTatyana Krokunova
Tatyana Krokunova
DMDenis Maksimov
Denis Maksimov
OMOlga Mityaeva
Olga Mityaeva
EAEkaterina Astakhova
Ekaterina Astakhova
PVPavel Volchkov
Pavel Volchkov
Adeno-associated viruses (AAVs) are non-pathogenic, replication-deficient viruses that have gained widespread attention for their application as gene therapy vectors. While these vectors offer high transduction efficiency and long-term gene expression, the host immune response poses a significant challenge to their clinical success. This review focuses on the obstacles to evaluating the humoral response to AAVs. We discuss the problems with the validation of in vitro tests and the possible approaches to overcome them. Using published data on neutralizing titers of AAV serotypes, we built the first antigenic maps of AAVs in order to visualize the antigenic relationships between varying serotypes.

10 December 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
DNDaria A Naumova
Daria A Naumova
TKTatyana Krokunova
Tatyana Krokunova
DMDenis Maksimov
Denis Maksimov
OMOlga Mityaeva
Olga Mityaeva
EAEkaterina Astakhova
Ekaterina Astakhova
PVPavel Volchkov
Pavel Volchkov
Adeno-associated viruses (AAVs) are non-pathogenic, replication-deficient viruses that have gained widespread attention for their application as gene therapy vectors. While these vectors offer high transduction efficiency and long-term gene expression, the host immune response poses a significant challenge to their clinical success. This review focuses on the obstacles of evaluating humoral response to AAVs. We discuss the problems with the validation of in vitro tests, and the possible approaches to overcome them. Using published data of neutralizing titers of AAV serotypes, we built the first antigenic maps of AAV in order to visualize the antigenic relationships between varying serotypes.